Table 2 Demographic, medical history and clinical characteristics at baseline
Characteristic | AbobotulinumtoxinA treated subjects (N = 1202) |
|---|---|
Sex (female); n (%) | 797 (66.3) |
Age; n (%) | |
 18–30 | 50 (4.2) |
 31–40 | 118 (9.8) |
 41–50 | 261 (21.7) |
 51–60 | 306 (25.5) |
 61–70 | 295 (24.5) |
  > 70 | 172 (14.3) |
Proportion subjects with CD family history; n (%) | 85 (7.1) |
Time since diagnosis (years); n (%) | |
  < 1 | 149 (12.4) |
 1–5 | 415 (34.6) |
  > 5 | 637 (53.0) |
 Missing | 1 |
Previous treatment with BoNT; n (%) | |
 Yes | 994 (82.8) |
 No | 206 (17.2) |
 Missing | 2 |
Use of concomitant medication; n (%) | 453 (37.7) |
Proportion with simple CD; n (%)* | 373 (31.1) |
Proportion with complex CD; n (%) | 821 (68.4) |
Predominant head/neck deviation pattern; n (%) | |
 Torticollis | 758 (64.1) |
 Laterocollis | 243 (20.5) |
 Retrocollis | 57 (4.8) |
 Anterocollis | 24 (2.0) |
 Lateral shift | 11 (0.9) |
 Sagittal shift | 10 (0.8) |
 Missing/not derived | 99 |
Secondary head/neck deviation pattern and associated components; n (%) | |
 Torticollis | 283 (34.3) |
 Laterocollis | 468 (56.7) |
 Retrocollis | 200 (24.2) |
 Anterocollis | 151 (18.3) |
 Lateral shift | 170 (20.6) |
 Sagittal shift | 78 (9.5) |
 No secondary pattern | 68 (5.7) |
 Missing/not derived | 309 |
CD component; n (%) | |
 Shoulder elevation; n (%) | 499 (71.6) |
 Tremor; n (%) | 393 (56.4) |
 Jerk; n (%) | 86 (12.3) |
 No component | 164 |
 Missing | 341 |
Tsui tremor score category; n (%) | |
 0 | 445 (47.2) |
 1 | 238 (25.3) |
 2 | 155 (16.5) |
 4 | 104 (11.0) |
Missing | 260 |
Tsui tremor severity category; n (%) | |
 None | 445 (47.2) |
 Mild | 381 (40.4) |
 Severe | 116 (12.3) |
 Missing | 260 |
Tsui tremor duration category; n (%) | |
 None | 445 (47.2) |
 Occasional | 250 (26.5) |
 Continuous | 247 (26.2) |
 Missing | 260 |
TWSTRS Total; mean ± SD** | 33.95 ± 12.46 |
TWSTRS Severity; mean ± SD** | 17.18 ± 5.13 |
TWSTRS Disability; mean ± SD** | 9.95 ± 6.30 |
TWSTRS Pain; mean ± SD** | 6.82 ± 4.94 |